Fig. 7.
XRCC1/ALDH2 mRNA level ratio has an increased predictive value compared to that of ALDH2 expression alone in lung and liver cancer patients. a Kaplan-Meier analysis of the 5-year overall survival of lung cancer patients (TCGA) stratified for XRCC1/ALDH2 mRNA level ratio (cut at the median). b Kaplan-Meier analysis of the 5-year overall survival of liver cancer patients (TCGA) stratified for XRCC1/ALDH2 mRNA level ratio (cut at the median). c Kaplan-Meier analysis of the 5-year overall survival of oesophageal cancer patients (TCGA) stratified for XRCC1/ALDH2 mRNA level ratio (cut at the median)